Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancerYoshinori Imamura, Hironobu Minami|Oncology Reports|2015Cited by 852
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO–ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOSTakayuki Yoshino, Jean‐Yves Douillard, Dirk Arnold et al.|Annals of Oncology|2017Cited by 591
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor FailureTimothy P. Hughes, Dong‐Wook Kim, Michael J. Mauro et al.|New England Journal of Medicine|2019Cited by 464
Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Yasuhiro Koh et al.|Journal of Clinical Oncology|2019Cited by 168
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Yuichi Takiguchi et al.|JAMA Oncology|2020Cited by 119